Company Filing History:
Years Active: 2008-2010
Title: Alpesh Patel: Innovator in Transfection Technologies
Introduction
Alpesh Patel is a distinguished inventor based in Cambridge, GB, known for his significant contributions to the field of biochemistry and molecular biology. With a total of four patents, Patel has focused his innovative efforts on developing novel transfection agents that facilitate the transfer of polynucleotides into cells, which has implications for gene therapy and biotechnology.
Latest Patents
Patel's latest patents include:
1. **Amide and peptide derivatives of tetraalkylenepentamines as transfection agents** - This invention relates to newly identified pentamine-based surfactant compounds and their production. It also encompasses the use of these compounds to enhance the transfer of polynucleotides into cells.
2. **Amide and peptide derivatives of dialkylenetriamines and their use as transfection agents** - This invention details spermidine-based surfactant compounds, including their applications and production methods. Similar to his previous work, this patent focuses on facilitating the transfer of polynucleotides into cells.
Career Highlights
Alpesh Patel is currently employed at Glaxo Group Limited, where he continues to push the boundaries of innovation in pharmaceutical sciences. His role involves extensive research and development, contributing to advancements in transfection methodologies and cellular biology.
Collaborations
In his professional journey, Patel has worked alongside notable colleagues, including Mariano Javier Castro and Christopher Kitson, enhancing collaborative efforts in research that have led to groundbreaking inventions and advancements in their field.
Conclusion
Alpesh Patel represents the forefront of innovation within the biochemistry sector, particularly in the realm of transfection technologies. His patents not only reflect his deep understanding and expertise but also underscore the importance of continued research in developing effective biomedical tools for the future.